Related Experiment Video
Updated: Sep 2, 2025

04:44
Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
20.1K
Differences in symptom experience among patients with systemic sclerosis: a cluster analytic approach to identifying
Susan L Murphy1,2,3, Yen T Chen1,3, Yvonne C Lee2
1Department of Physical Medicine and Rehabilitation.
Rheumatology (Oxford, England)
|August 3, 2022
Summary
Researchers identified three symptom subgroups in systemic sclerosis (SSc) patients: minimal, mild, and moderate. The moderate group experienced co-occurring pain, fatigue, sleep issues, depression, and anxiety, suggesting tailored treatment approaches for SSc symptom clusters.
Area of Science:
- Rheumatology
- Clinical Medicine
- Patient-Reported Outcomes
Background:
- Systemic sclerosis (SSc) presents with diverse and clinically challenging symptoms.
- Understanding symptom co-occurrence and underlying mechanisms is crucial for targeted SSc treatments.
- Identifying distinct patient subgroups based on symptom experience can refine therapeutic strategies.
Purpose of the Study:
- To identify and characterize patient subgroups within a systemic sclerosis (SSc) cohort based on their symptom experience.
- To explore potential differences in symptom presentation and underlying mechanisms across identified SSc subgroups.
Main Methods:
- Exploratory hierarchical agglomerative cluster analysis on a cohort of 587 SSc patients.
- Utilized patient-reported outcomes for pain interference, fatigue, sleep disturbance, dyspnoea, depression, and anxiety for clustering.
- Multivariate analysis of variance (MANOVA) and analyses of variance (ANOVA) were employed to examine subgroup characteristics and variable contributions.
Main Results:
- Cluster analysis revealed three distinct SSc subgroups based on symptom severity: no/minimal, mild, and moderate.
- The mild symptom subgroup was characterized by primary clusters of pain, fatigue, and sleep disturbance.
- The moderate symptom subgroup exhibited co-occurring pain, fatigue, sleep disturbance, depression, and anxiety, despite similar disease severity to the mild group.
Conclusions:
- Distinct symptom clusters identified in SSc patients, particularly in mild and moderate groups, indicate potential differences in treatment approaches.
- These findings suggest the need for further investigation into the mechanisms underlying symptom experience in SSc.
- Tailoring treatment based on identified symptom clusters may improve clinical management of SSc.

